Brief: Implantica Q1 Net Sales Rise To EUR 198 000
11/05/2022 07:15
May 11 (Reuters) - Implantica AG 8IM1q.F :
* IMPLANTICA PUBLISHES INTERIM REPORT Q1, JANUARY - MARCH
2022
* Q1 NET SALES INCREASED 141% TO TEUR 198 (82).
* Q1 OPERATING LOSS (EBIT) DECREASED TO TEUR 4,411 (2,279)
* Q1 LOSS AFTER TAX AMOUNTED TO TEUR 4,888 (1,966)
Source text for Eikon: ID:nWkr4mZ48F
Further company coverage: 8IM1q.F
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3